AAAAAA
Results: 551-568/568
Authors:
BALEMANS LTM
MATTIJSSEN V
STEERENBERG PA
VANDRIEL BEM
DEMULDER PHM
DENOTTER W
Citation: Ltm. Balemans et al., LOCOREGIONAL THERAPY WITH POLYETHYLENE-GLYCOL-MODIFIED INTERLEUKIN-2 OF AN INTRADERMALLY GROWING HEPATOCELLULAR-CARCINOMA IN THE GUINEA-PIGINDUCES T-CELL-MEDIATED ANTITUMOR-ACTIVITY, Cancer immunology and immunotherapy, 37(1), 1993, pp. 7-14
Authors:
KANMITCHELL J
HUANG XQ
STEINMAN L
OKSENBERG JR
HAREL W
PARKER JW
GOEDEGEBUURE PS
DARROW TL
MITCHELL MS
Citation: J. Kanmitchell et al., CLONAL ANALYSIS OF INVIVO ACTIVATED CD8-LYMPHOCYTES FROM A MELANOMA PATIENT RESPONSIVE TO ACTIVE SPECIFIC IMMUNOTHERAPY( CYTOTOXIC T), Cancer immunology and immunotherapy, 37(1), 1993, pp. 15-25
Authors:
BUESCHER ES
MCILHERAN SM
BANKS SM
KUDELKA AP
KAVANAGH JJ
VADHANRAJ S
Citation: Es. Buescher et al., THE EFFECTS OF INTERLEUKIN-1 THERAPY ON PERIPHERAL-BLOOD GRANULOCYTE FUNCTION IN HUMANS, Cancer immunology and immunotherapy, 37(1), 1993, pp. 26-30
Authors:
BRIGHT RK
SHEARER MH
KENNEDY RC
Citation: Rk. Bright et al., COMPARISON OF THE MURINE HUMORAL IMMUNE-RESPONSE TO RECOMBINANT SIMIAN VIRUS-40 LARGE TUMOR-ANTIGEN - EPITOPE SPECIFICITY AND IDIOTYPE EXPRESSION, Cancer immunology and immunotherapy, 37(1), 1993, pp. 31-39
Authors:
PRIGIONE I
FACCHETTI P
LANINO E
GARAVENTA A
PISTOIA V
Citation: I. Prigione et al., CLONAL ANALYSIS OF PERIPHERAL-BLOOD LYMPHOCYTES FROM 3 PATIENTS WITH ADVANCED NEUROBLASTOMA RECEIVING RECOMBINANT INTERLEUKIN-2 AND INTERFERON-ALPHA, Cancer immunology and immunotherapy, 37(1), 1993, pp. 40-46
Authors:
NOURI AME
DOREY E
DAVIS CL
ROHATINER A
LISTER TA
OLIVER RTD
Citation: Ame. Nouri et al., GENERATION OF CYTOTOXIC T-LYMPHOCYTES FROM PERIPHERAL-BLOOD OF LEUKEMIC PATIENTS, Cancer immunology and immunotherapy, 37(1), 1993, pp. 47-53
Authors:
CASALINI P
CALDERA M
CANEVARI S
MENARD S
MEZZANZANICA D
TOSI E
GADINA M
COLNAGHI MI
Citation: P. Casalini et al., A CRITICAL COMPARISON OF 3 INTERNALIZATION ASSAYS APPLIED TO THE EVALUATION OF A GIVEN MAB AS A TOXIN-CARRIER CANDIDATE, Cancer immunology and immunotherapy, 37(1), 1993, pp. 54-60
Authors:
RON IG
INBAR MJ
GUTMAN M
MERIMSKY O
CHAITCHIK S
Citation: Ig. Ron et al., RECOMBINANT INTERFERON ALPHA-2A IN COMBINATION WITH DACARBAZINE IN THE TREATMENT OF METASTATIC MALIGNANT-MELANOMA - ANALYSIS OF LONG-TERM RESPONDING PATIENTS, Cancer immunology and immunotherapy, 37(1), 1993, pp. 61-66
Authors:
SIESJO P
VISSE E
LINDVALL M
SALFORD L
SJOGREN HO
Citation: P. Siesjo et al., IMMUNIZATION WITH MUTAGEN-TREATED (TUM-) CELLS CAUSES REJECTION OF NONIMMUNOGENIC RAT GLIOMA ISOGRAFTS, Cancer immunology and immunotherapy, 37(1), 1993, pp. 67-74
Authors:
HILLMAN GG
ROESSLER N
FULBRIGHT RS
PONTES JE
HAAS GP
Citation: Gg. Hillman et al., APPLICATION OF THE DIRECT BETA-COUNTER MATRIX-96 FOR CYTOTOXIC ASSAYS- SIMULTANEOUS PROCESSING AND READING OF 96 WELLS USING A CR-51 RETENTION ASSAY, Cancer immunology and immunotherapy, 36(6), 1993, pp. 351-356
Authors:
DOHI Y
SUNADA S
AOKI M
MORIGUCHI A
OKABAYASHI M
MIYATA M
MATSUDA H
Citation: Y. Dohi et al., ERADICATION OF METASTATIC TUMOR-CELLS FROM LYMPH-NODES BY LOCAL-ADMINISTRATION OF ANTI-CD3 ANTIBODY, Cancer immunology and immunotherapy, 36(6), 1993, pp. 357-363
Authors:
ALOSCO T
CROY BA
GANSBACHER B
WANG HQ
RAO U
BANKERT R
Citation: T. Alosco et al., ANTITUMOR RESPONSE INDEPENDENT OF FUNCTIONAL B-LYMPHOCYTES OR T-LYMPHOCYTES INDUCED BY THE LOCAL AND SUSTAINED-RELEASE OF INTERLEUKIN-2 BY THE TUMOR-CELLS, Cancer immunology and immunotherapy, 36(6), 1993, pp. 364-372
Authors:
SHITARA K
KUWANA Y
NAKAMURA K
TOKUTAKE Y
OHTA S
MIYAJI H
HASEGAWA M
HANAI N
Citation: K. Shitara et al., A MOUSE HUMAN CHIMERIC ANTI-(GANGLIOSIDE-GD3) ANTIBODY WITH ENHANCED ANTITUMOR ACTIVITIES, Cancer immunology and immunotherapy, 36(6), 1993, pp. 373-380
Authors:
KILLION JJ
RADINSKY R
DONG ZY
FISHBECK R
WHITWORTH P
FIDLER IJ
Citation: Jj. Killion et al., THE IMMUNOGENIC PROPERTIES OF DRUG-RESISTANT MURINE TUMOR-CELLS DO NOT CORRELATE WITH EXPRESSION OF THE MDR PHENOTYPE, Cancer immunology and immunotherapy, 36(6), 1993, pp. 381-386
Authors:
CZUCZMAN MS
GARINCHESA P
LEMOLI RM
SCHEINBERG DA
Citation: Ms. Czuczman et al., IGM MONOCLONAL-ANTIBODY JD118 RECOGNIZES AN INDUCIBLE ANTIGEN TARGET FOR HUMAN-COMPLEMENT-MEDIATED CYTOTOXICITY AGAINST NEOPLASTIC B-CELLS, Cancer immunology and immunotherapy, 36(6), 1993, pp. 387-396
Authors:
SRINIVAS U
TAGLIABUE E
CAMPIGLIO M
MENARD S
COLNAGHI MI
Citation: U. Srinivas et al., ANTIBODY-INDUCED ACTIVATION OF P185(HER2) IN THE HUMAN LUNG ADENOCARCINOMA CELL-LINE CALU-3 REQUIRES BIVALENCY, Cancer immunology and immunotherapy, 36(6), 1993, pp. 397-402
Authors:
KUPPEN PJK
EGGERMONT AMM
SMITS KM
VANEENDENBURG JDH
LAZEROMS SPG
VANDEVELDE CJH
FLEUREN GJ
Citation: Pjk. Kuppen et al., THE DEVELOPMENT AND PURIFICATION OF A BISPECIFIC ANTIBODY FOR LYMPHOKINE-ACTIVATED KILLER-CELL TARGETING AGAINST THE RAT COLON-CARCINOMA CC531, Cancer immunology and immunotherapy, 36(6), 1993, pp. 403-408
Authors:
RUFFINI PA
RIVOLTINI L
SILVANI A
BOIARDI A
PARMIANI G
Citation: Pa. Ruffini et al., FACTORS, INCLUDING TRANSFORMING GROWTH-FACTOR-BETA, RELEASED IN THE GLIOBLASTOMA RESIDUAL CAVITY, IMPAIR ACTIVITY OF ADHERENT LYMPHOKINE-ACTIVATED KILLER-CELLS, Cancer immunology and immunotherapy, 36(6), 1993, pp. 409-416